Japan’s regulator has quickly approved Gilead’s remdesivir for patients with severe COVID-19, after the FDA allowed its use as an emergency treatment for the disease earlier this month.
There are doubts about the US government's plans to have 300 million COVID-19 vaccine doses ready by the end of the year, after the front-running candidate from Moderna advanced to mid-stag
As the UK went into COVID-induced lockdown, Matthew and Hayley Smith were receiving the news they had dreaded for four years – that Matthew’s brain tumour had come back.